$2.13
-0.01-0.47%
At close: -
$2.11
-0.02-0.90%
After Hours: Feb 14, 5:48 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Akebia Therapeutics in recent months.
Browse guidance and forecast on all stocks.